Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership
TOKYO and WESTBOROUGH, Mass., Dec 15, 2025 – (JCN Newswire via SeaPRwire.com) – Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer, and more fulfilling, has announced an additional commitment to its corporate venture capital fund, Olympus Innovation Ventures, LLC (OIV), with the launch of Olympus Innovation Ventures Fund II. Building on the success of the initial fund, Olympus will deploy $150 million to invest in promising MedTech startup companies focused on Gastrointestinal (GI), Urology and Respiratory.Abigail Hunter-Syed, Head of OIV, speaking at The MedTech Conference 2025(photo courtesy of MedTech Innovator)OIV, a wholly owned subsidiary of Olympus Corporation of the Americas, aims to generate a robust pipeline of M&A opportunities, partnerships, and valuable market insights. OIV is stage-agnostic, prioritizing early to growth-stage companies globally with therapeutic solutions for targeted medical specialties. In addition to capital, O…
